NCT03415399
- Conditions
- Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
- Locations
-
- Peking University Cancer Hospital Beijing, China
Clinical trial condition
Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.
NCT03415399
NCT03262389
NCT01659255
NCT00278421
NCT01207921
NCT00495079
NCT01110863
NCT02165397
NCT03562910
NCT01110850